The federal government program providing free at-home COVID-19 tests has announced that it is currently “not accepting orders ...

Labcorp lists the plant as part of its consumer genetics business and plans to begin eliminating positions in May.

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). A SARS-CoV-2 antibody, NT-108, exhibits potent ...

In the previous month, the company’s Labcorp Plasma Complete, a circulating tumor DNA-based comprehensive genomic profiling ...

On the 5-year anniversary of the start of the COVID-19 pandemic, CEOs said the crisis taught them to respond faster and ...

WASHINGTON — The U.S. government's free at-home COVID-19 test distribution program has been suspended and is no longer ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

As of March 10, the government's free coronavirus test distribution program, COVIDtests.gov, is not currently accepting orders, the Administration for Strategic Preparedness and Response website says.

Ibrahim Rayintakath Supported by By Dani Blum Nina Agrawal and Alice Callahan Five years — and hundreds of millions of cases — after the World Health Organization declared the Covid-19 ...

Gloucester will mark the National Day of Reflection, honouring those who lost their lives during the pandemic by officially unveiling its Covid-19 Memorial in Gloucester Park on Sunday March 9.

Specifically, Qiagen said the patent covers important innovations in the company's QuantiFeron-TB Gold Plus test. Qiagen did not name the infringing BioMérieux product or products in its statement, ...

A promising orally bioavailable once-daily form has been an animal test by our partner Entera Bio ... to accelerate our development of the COVID multispecific antibody and $16 million into ...